Diabetic nephropathy in 2014: Improved cardiorenal prognosis in diabetic nephropathy
Research output: Contribution to journal › Review › Research › peer-review
In 2014, key studies in the field of diabetic nephropathy highlighted the importance of albuminuria as a predictor of cardiovascular risk and showed that the incidence of renal and cardiovascular complications is decreasing. Promising efficacy data were obtained with atrasentan, whereas a trial of bardoxolone methyl led to safety concerns.
Original language | English |
---|---|
Journal | Nature Reviews Gastroenterology and Hepatology |
Volume | 12 |
Issue number | 1 |
Pages (from-to) | 47-49 |
Number of pages | 3 |
ISSN | 1759-5045 |
Publication status | Published - 1 Jan 2015 |
ID: 257058843